Cargando...
Metabolic reprogramming of myeloid-derived suppressor cells (MDSC) in cancer
MDSC undergo metabolic reprogramming in the tumor resulting in an increased fatty acid β oxidation that supports their immunosuppressive functions. Fatty acid oxidation inhibitors, used to treat coronary disease, significantly delayed tumor growth and had a significantly increased antitumor effect w...
Guardado en:
| Publicado en: | Oncoimmunology |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Taylor & Francis
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5007951/ https://ncbi.nlm.nih.gov/pubmed/27622069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1200771 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|